Contract on 15 MeV Electron Linac confirms RI Research Instruments’ global leadership in turnkey accelerating systems and is the first major order for RI Research Instruments, formerly part of ACCEL Instruments.

Bergisch Gladbach, Germany - May 4, 2009 - RI Research Instruments GmbH, a majority-owned subsidiary of Bruker Advanced Supercon, Inc., announced today the finalization of an approximately $4 million contract with Radboud University, Nijmegen, Netherlands on a turn-key infrared free electron laser (IR FEL) driver.

The contract covers the development, production, installation and commissioning of a 8-15MeV pulsed linear accelerator (linac) with parameters suitable to drive the IR FEL, which will be developed in parallel by the team at the Radboud University.

The contract is the first major order received by RI Research Instruments since the formation of this company in connection with Bruker’s April 1, 2009 acquisition of the research instruments business of ACCEL Instruments from Varian Medical Systems.

“This contract ideally complements our work on the 150 MeV Linac for the Taiwan Photon Source and the production of S-Band accelerating cavities for the Paul Scherrer Institut in Switzerland. Besides high micro pulse charge at low energy spread, the requirements of building a compact and efficient electron source make this project a new challenge for the teams at RI Research Instruments and Radboud University,” explained Michael Peiniger, managing director of RI Research Instruments. “It also shows continuity in serving our customers and we are very thankful to Radboud University for the confidence expressed in RI with this order.”

About RI Research Instruments:

RI Research Instruments GmbH is a world leader in the development and manufacturing of rf cavities and systems, linear accelerators, and special products for physics and energy research, scientific, medical, and industrial applications. RI products include electron and ion sources, linacs, superconducting and normal conducting accelerator cavities, other accelerator components, neutron source subunits, particle beam lines, as well as vacuum and cryogenic systems. RI Research Instruments was formed as a result of Bruker Advanced Supercon’s April 1, 2009 acquisition of the research instruments business of ACCEL Instruments GmbH from Varian Medical Systems. Bruker has acquired a majority stake in RI Research Instruments but has retained Dr. Michael Peiniger as managing director and the former ACCEL management team as minority (45%) shareholders in the newly formed company. Bruker Advanced Supercon, Inc. of Billerica, MA is a wholly-owned subsidiary of Bruker Corporation (NASDAQ: BRKR) and has operations in the U.S., Scotland (Hydrostatic Extrusions Limited), and Germany (Bruker EAS, Bruker HTS, RI Research Instruments, and Bruker Advanced Supercon GmbH, another company formed in connection with the acquisition of the research instruments business of ACCEL Instruments).

RI Research Instruments GmbH Contact:

Dr. Michael Peiniger
Managing Director, RI Research Instruments
Tel: +49 2204 843676
eMail: michael.peiniger@research-instruments.de